Return to site

Vascular Closure Devices Market | Key Players - Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), and Cardiva Medical Inc. (U.S.)

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.

· Medical Devices,Healthcare

In 2017, passive approximators segment accounted for the largest share of ~ 67% of the global vascular closure device market. The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery. The passive approximators segment is further divided into collagen plugs, sealant or gel-based devices, and compression assist devices. The large share of this market can be attributed to the large number of approvals for vascular closure devices and the high prevalence of cardiovascular disease and obesity. However, the high cost of vascular closure devices and the increasing popularity of interventional procedures using radial arteries are likely to limit market growth to a certain extent.

Vascular Closure Device Market

The global vascular closure device market is expected to reach USD 984.6 million by 2022. The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.

radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.

Early buyers will receive 10% customization on this report –https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=180101468

Key Players

The major players in this market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly